LYVANTA

Owners

Goods & Services

Fertility-enhancing drugs; pharmaceuticals and medical preparations, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies for stimulating ovulation to aid in conception; pharmaceutical and medical preparations for fertility treatments, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies for stimulating ovulation to aid in conception; ovulation stimulants, namely, pharmaceutical preparations for stimulating ovulation; pharmaceutical drugs that stimulate ovulation to aid in conception; dietary supplements for reproductive health; diagnostic reagents for medical use; dietary supplements to support implantation of embryos; hormonal therapies being pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and support of hormonal disorders; In vitro fertilization (IVF) diagnostic preparations for medical purposes; cell cryopreservation solutions for medical purposes, namely, solutions for medical and clinical use in storing and treating cells, blood, and blood components; semen analysis kits comprised of semen analyzing devices for medical purposes; endometrial receptivity tests for medical purposes; luteal phase support in the form of dietary supplements; tests to measure ovarian reserve and predict response to fertility treatments for medical use; tests to evaluate ovarian function and fertility potential for medical use; nutrient solutions for medical and clinical use to support the growth of embryos in the lab